Track topics on Twitter Track topics that are important to you
738, rue Yves-Kermen
Phone: 33 (0)1 47 61 13 13
Fax: 33 (0)1 47 61 00 01
In this episode of PharmaTelevision News Review, Paul Larsmon talks with Roel Bulthuis, Head at Merck Serono Ventures. Filmed at BIO-Europe 2009, they discuss: • Merck Serono's new corporate venture...
In this episode of PharmaTelevision News Review, Fintan Walton talks to Roel Bulthuis, Head of Merck Serono Ventures of Merck Serono SA
In March 2009 Merck Serono announced that they had set up a strategic Venture Fund to invest in biotech companies with interesting programmes that are in line with Merck Serono’s strategic thinking....
In this episode of PharmaTelevision News Review, Fintan Walton talks to Phillippe Lopes-Fernandes, Corporate VP, Head of Global Business Development at Merck Serono
In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Philippe M Lopes-Fernandes, Senior VP, Head of Global Licensing, Business ...
Merck Serono suspends trials of Stimuvax cancer vaccine after encephalitis case
Sussman to lead the company's government policy strategy and advocacy efforts
Acquires Merck Serono’s diabetes candidate imeglimin as part of the deal
CD Hydra Life Pro-Youth Protective Creme SPF 15
CD Hydra Life Pro-Youth Protective Fluid
Rouge Dior Serum de Rouge Luminous Color Lip Treatment 660
Rouge Dior Serum de Rouge Luminous Color Lip Treatment 850
Rouge Dior Serum de Rouge Luminous Color Lip Treatment 650
Poppers have become legal in France since June 2013. Is their liberalisation associated with an increase of severe side effects observed?
In November 2017, a 15-day-old calf located in France (Haute-Savoie department) was found positive for bluetongue virus (BTV) RNA by RT-PCR. Laboratory investigations allowed the isolation and identif...
General Practitioners (GPs) are the leading antidepressants prescribers in Europe and in France. Difficulties in implementing existing recommendations in daily practice have been described.
Purpose of the study is the comparative evaluation of the clinical efficacy and of the general tolerability of two different subcutaneous FSH preparations (Fostimon® IBSA Vs Gonal-F® Ser...
Darmstadt, Germany, June 17 2010 - Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome ...
The transparency commission wishes that the laboratory Lilly France sets up a follow-up study describing the conditions of use of Xigris® in France. The purpose of this study is to descr...
Very few data has been published on the epidemiology of hypoparathyroidism worldwide: none exists specifically for France. Hypoparathyroidism could led to complications. Here, the investig...
ID in children is the most frequent micronutrient deficiency in industrialized countries, including France. ID induces neurological impairment reducing cognitive, motor, and behavioral cap...
Merck Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono ...
Serono is a global biotechnology leader with over 4,750 employees and worldwide revenues of USD 2,586.4 million in the year 2005. We have eight biotechnology products on the market and currently more ...
We develop innovative products to fight debilitating diseases and improve the lives of our patients.We aspire to create an environment that enables our people to excel and innovate and to contribute t...
We have published hundreds of Serono France SA news stories on BioPortfolio along with dozens of Serono France SA Clinical Trials and PubMed Articles about Serono France SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Serono France SA Companies in our database. You can also find out about relevant Serono France SA Drugs and Medications on this site too.